Cargando…

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

Objective. MTX is widely used to treat synovitis in PsA without supporting trial evidence. The aim of our study was to test the value of MTX in the first large randomized placebo-controlled trial (RCT) in PsA. Methods. A 6-month double-blind RCT compared MTX (15 mg/week) with placebo in active PsA....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kingsley, Gabrielle H., Kowalczyk, Anna, Taylor, Helen, Ibrahim, Fowzia, Packham, Jonathan C., McHugh, Neil J., Mulherin, Diarmuid M., Kitas, George D., Chakravarty, Kuntal, Tom, Brian D. M., O'Keeffe, Aidan G., Maddison, Peter J., Scott, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397466/ https://www.ncbi.nlm.nih.gov/pubmed/22344575 http://dx.doi.org/10.1093/rheumatology/kes001

Ejemplares similares

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial
por: Scott, David L, et al.
Publicado: (2015)

A case-study in the clinical epidemiology of psoriatic arthritis: multistate models and causal arguments
por: O'Keeffe, Aidan G, et al.
Publicado: (2011)

Mixture distributions in multi-state modelling: Some considerations in a study of psoriatic arthritis
por: O'Keeffe, Aidan G, et al.
Publicado: (2013)

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
por: Bulatović Ćalasan, Maja, et al.
Publicado: (2013)

Psoriatic Arthritis with Acral Lentiginous Melanoma: Role for Methotrexate?
por: Rahima, S, et al.
Publicado: (2013)

Is there still a place for methotrexate in severe psoriatic arthritis?
por: Felten, Renaud, et al.
Publicado: (2022)

Effectiveness, Safety and Tolerance of Methotrexate in Vietnamese Psoriatic Arthritis Patients
por: Thi, Van Bui, et al.
Publicado: (2019)

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
por: Baranauskaite, Asta, et al.
Publicado: (2011)

The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis
por: Liu, Yong, et al.
Publicado: (2014)

Treatment recommendations for psoriatic arthritis
por: Ritchlin, C T, et al.
Publicado: (2009)

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study
por: Lindström, Ulf, et al.
Publicado: (2023)

Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort
por: Bowes, John, et al.
Publicado: (2012)

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)
por: Mulder, Michelle L. M., et al.
Publicado: (2020)

Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
por: Bowes, John, et al.
Publicado: (2011)

Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis
por: Jadon, Deepak R, et al.
Publicado: (2017)

First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine
por: Jacobs, Marleen E, et al.
Publicado: (2020)

Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
por: Kingsley, Gabrielle H, et al.
Publicado: (2015)

A qualitative study of patients’ experiences of screening for psoriatic arthritis
por: Silverthorne, Christine A., et al.
Publicado: (2022)

Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis
por: Day, T G, et al.
Publicado: (2008)

16. Reactivation of hepatitis B virus in a patient with psoriatic arthritis treated with methotrexate
por: Mudawi, Tareg, et al.
Publicado: (2017)

10. Reactivation of hepatitis B virus in a patient with psoriatic arthritis treated with methotrexate
por: Mudawi, Tareg, et al.
Publicado: (2017)

Methotrexate-Related Liver Cirrhosis in Psoriatic Arthritis: A Case Report and Review of the Literature
por: Koutsompina, Maria-Loukia, et al.
Publicado: (2021)

MTHFR Gene Polymorphism Association With Psoriatic Arthritis Risk and the Efficacy and Hepatotoxicity of Methotrexate in Psoriasis
por: Zhu, Jie, et al.
Publicado: (2022)

Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis
por: SADOGHI, Birgit, et al.
Publicado: (2021)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
por: Coates, Laura C, et al.
Publicado: (2020)

Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial
por: de Jong, Henriëtte M. Y., et al.
Publicado: (2019)

Psoriatic arthritis
por: Ocampo D, Vanessa, et al.
Publicado: (2019)

Diagnosis and initial management in psoriatic arthritis: a qualitative study with patients
por: Dures, Emma, et al.
Publicado: (2019)

Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study
por: Dures, Emma, et al.
Publicado: (2017)

Exploring the illness representations of people with psoriatic arthritis: a secondary analysis of focus group data
por: Erskine, George, et al.
Publicado: (2018)

Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
por: Mease, Philip J, et al.
Publicado: (2018)

Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study
por: Clunie, Gavin, et al.
Publicado: (2018)

Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis
por: Bowes, John, et al.
Publicado: (2010)

Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study
por: Dehpouri, Tannaz, et al.
Publicado: (2019)

Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
por: Mease, Philip J., et al.
Publicado: (2022)

Correction to: Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study
por: Dures, Emma, et al.
Publicado: (2019)

Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis
por: Green, Amelia, et al.
Publicado: (2021)

A Case of Multicentric Carcinoid in a Patient with Psoriatic Spondyloarthropathy
por: George, Nabil, et al.
Publicado: (2015)

Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
por: Ogdie, Alexis, et al.
Publicado: (2022)

Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris
por: Bowes, John, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4iqrk7gpvbs5b9mj3u6srftde8